Back to today’s briefing

Story perspectives

Ezogabine: New Hope for Depression Treatment Revealed

5/23/2025

38 3

Summary

Story summary

Exciting research from Mount Sinai Hospital uncovers that ezogabine, originally designed for epilepsy, could be a game-changer for depression. By targeting potassium channels, it revitalizes brain areas tied to pleasure while dampening connections to negativity. This breakthrough hints at a promising new approach for tackling major depressive disorder and anhedonia.

1 of 1

Story summary

Exciting research from Mount Sinai Hospital uncovers that ezogabine, originally designed for epilepsy, could be a game-changer for depression. By targeting potassium channels, it revitalizes brain areas tied to pleasure while dampening connections to negativity. This breakthrough hints at a promising new approach for tackling major depressive disorder and anhedonia.